Literature DB >> 29106466

Nivolumab in HIV-related non-small-cell lung cancer.

M Hentrich1, K Schipek-Voigt2, H Jäger3, S Schulz4, P Schmid4, O Stötzer2, P Bojko4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29106466     DOI： 10.1093/annonc/mdx321

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

Review 1.  Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer.

Authors:  Kathryn Lurain; Ramya Ramaswami; Robert Yarchoan; Thomas S Uldrick
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

2.  Nivolumab Treatment for Cancers in the HIV-infected Population.

Authors:  Elaine Chang; Anita L Sabichi; Jennifer R Kramer; Christine Hartman; Kathryn E Royse; Donna L White; Niraj R Patel; Peter Richardson; Sarvari V Yellapragada; Jose M Garcia; Elizabeth Y Chiao
Journal:  J Immunother       Date:  2018-10       Impact factor: 4.456

3.  Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy.

Authors:  Xuanye Zhang; Dan Tian; Yue Chen; Chen Chen; Li-Na He; Yixin Zhou; Haifeng Li; Zuan Lin; Tao Chen; Yuhong Wang; Alessandro Russo; Ernest Nadal; Francesco Passiglia; Ross Andrew Soo; Satoshi Watanabe; Teresa Moran; In-Jae Oh; Sha Fu; Shaodong Hong; Li Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-07

4.  Pembrolizumab combined with stereotactic body radiotherapy in a patient with human immunodeficiency virus and advanced non-small cell lung cancer: a case report.

Authors:  Dongqi Li; Chuanchun He; Yaoxiong Xia; Yaxi Du; Jing Zhang
Journal:  J Med Case Rep       Date:  2018-04-23

5.  Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection.

Authors:  Muhammad Husnain; Wungki Park; Juan Carlos Ramos; Thomas E Johnson; Joseph Chan; Arvind Dasari; Raja Mudad; Peter J Hosein
Journal:  J Immunother Cancer       Date:  2018-07-09       Impact factor: 13.751

Review 6.  Immunotherapy in People With HIV and Cancer.

Authors:  Camille E Puronen; Emily S Ford; Thomas S Uldrick
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

7.  HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo.

Authors:  Zhengtao Jiang; Huitong Liang; Hanyu Pan; Yue Liang; Hua Wang; Xinyi Yang; Panpan Lu; Xiao Zhang; Jinlong Yang; Dengji Zhang; Xiaoting Shen; Jing Wang; Zhiming Liang; Qinru Lin; Yanan Wang; Lin Zhao; Yangcheng Zhong; Hongzhou Lu; Huanzhang Zhu
Journal:  Front Microbiol       Date:  2021-07-06       Impact factor: 5.640

Review 8.  Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection.

Authors:  Yuting Sun; Jing Xue
Journal:  Viruses       Date:  2022-03-11       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.